NSE BSE
shree ganesh biotech (india) l stock

Shree Ganesh Biotech (India) L Share Price

- - (%)
- NSE: SHREEGANES

Shree Ganesh Biotech (India) L Share Price Update

As of the latest trading session, Shree Ganesh Biotech (India) L share price is currently at 1.21, which is down by -0.03 from its previous closing. Today, the stock has fluctuated between 1.13 and 1.26. Over the past year, Shree Ganesh Biotech (India) L has achieved a return of 19.04 %. In the last month alone, the return has been 9.64 %. Read More...

Shree Ganesh Biotech (India) L Performance

Day Range

Low1.13 High1.26
1.21

52 Week Range

Low .70 High 1.89
1.21

Shree Ganesh Biotech (India) L Share Price

539470

SHREEGANES

img img img img
No Data Available

Open Price

1.25

Prev. Close

1.25

Volume (Shares)

1949602.00

Total traded value

23.61

Upper Circuit

.00

Lower Circuit

.00

Note: The current prices & values are delayed, Login to your account for live updates.

Shree Ganesh Biotech (India) L Fundamentals


(Standalone)

Market Cap (Cr) 48.20
PE Ratio (TTM) 62.50
Book Value / Share 1.57
Beta 0.45
ROE 3.33%
EPS (TTM) 0.02
Dividend Yield 0.00%
Net Profit Qtr (Cr) 0.54

Shree Ganesh Biotech (India) L Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars MAR 2024 (Values in Cr)
Revenue 3.78
Operating Expense 4.30
Net Profit 0.54
Net Profit Margin (%) 14.28
Earnings Per Share (EPS) 0.01
EBITDA 0.54
Effective Tax Rate (%) 0.00
Particulars DEC 2023 (Values in Cr)
Revenue 4.12
Operating Expense 4.04
Net Profit 0.09
Net Profit Margin (%) 2.18
Earnings Per Share (EPS) 0.00
EBITDA 0.09
Effective Tax Rate (%) 0.00
Particulars SEP 2023 (Values in Cr)
Revenue 4.12
Operating Expense 4.04
Net Profit 0.08
Net Profit Margin (%) 1.94
Earnings Per Share (EPS) 0.00
EBITDA 0.08
Effective Tax Rate (%) 0.00
Particulars JUN 2023 (Values in Cr)
Revenue 8.25
Operating Expense 8.10
Net Profit 0.15
Net Profit Margin (%) 1.81
Earnings Per Share (EPS) 0.00
EBITDA 0.15
Effective Tax Rate (%) 0.00
Particulars MAR 2023 (Values in Cr)
Revenue 7.98
Operating Expense 8.47
Net Profit 0.10
Net Profit Margin (%) 1.25
Earnings Per Share (EPS) 0.00
EBITDA 0.10
Effective Tax Rate (%) 0.00
Particulars MAR 2024 (Values in Cr)
Revenue 20.28
Operating Expense 20.48
Net Profit 0.62
Net Profit Margin (%) 3.05
Earnings Per Share (EPS) 0.02
EBITDA 0.85
Effective Tax Rate (%) 27.05
Particulars MAR 2023 (Values in Cr)
Revenue 62.45
Operating Expense 60.31
Net Profit 2.04
Net Profit Margin (%) 3.26
Earnings Per Share (EPS) 0.05
EBITDA 2.71
Effective Tax Rate (%) 25.09
Particulars MAR 2022 (Values in Cr)
Revenue 72.64
Operating Expense 69.20
Net Profit 2.53
Net Profit Margin (%) 3.48
Earnings Per Share (EPS) 0.13
EBITDA 3.50
Effective Tax Rate (%) 27.71
Particulars MAR 2021 (Values in Cr)
Revenue 17.21
Operating Expense 16.51
Net Profit 0.32
Net Profit Margin (%) 1.85
Earnings Per Share (EPS) 0.02
EBITDA 0.43
Effective Tax Rate (%) 25.58
Particulars MAR 2020 (Values in Cr)
Revenue 2.47
Operating Expense 2.24
Net Profit 0.24
Net Profit Margin (%) 9.71
Earnings Per Share (EPS) 0.12
EBITDA 0.24
Effective Tax Rate (%) 0.00
Particulars MAR 2023 (Values in Cr)
Book Value / Share 1.56
ROE % 3.33
ROCE % 4.43
Total Debt to Total Equity 0.00
EBITDA Margin 4.34
Particulars MAR 2022 (Values in Cr)
Book Value / Share 3.03
ROE % 4.28
ROCE % 5.92
Total Debt to Total Equity 0.00
EBITDA Margin 4.82
Particulars MAR 2021 (Values in Cr)
Book Value / Share 29.00
ROE % 0.92
ROCE % 1.23
Total Debt to Total Equity 0.00
EBITDA Margin 4.13
Particulars MAR 2020 (Values in Cr)
Book Value / Share 28.84
ROE % 0.42
ROCE % 0.42
Total Debt to Total Equity 0.00
EBITDA Margin 9.72
Particulars MAR 2019 (Values in Cr)
Book Value / Share 28.72
ROE % 4.47
ROCE % 4.45
Total Debt to Total Equity 0.00
EBITDA Margin 30.49
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.48
Total Assets 79.52
Total Liabilities 79.52
Total Equity 62.35
Share Outstanding 398624000
Price to Book Ratio 0.65
Return on Assets (%) 2.56
Return on Capital (%) 3.27
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.03
Total Assets 93.55
Total Liabilities 93.55
Total Equity 60.31
Share Outstanding 199312000
Price to Book Ratio 3.07
Return on Assets (%) 2.69
Return on Capital (%) 4.19
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.02
Total Assets 74.62
Total Liabilities 74.62
Total Equity 57.79
Share Outstanding 19931200
Price to Book Ratio 4.09
Return on Assets (%) 0.42
Return on Capital (%) 0.55
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 0.01
Total Assets 64.71
Total Liabilities 64.71
Total Equity 57.47
Share Outstanding 19931200
Price to Book Ratio 4.51
Return on Assets (%) 0.36
Return on Capital (%) 0.41
Particulars MAR 2019 (Values in Cr)
Cash & Short Term Investments 0.03
Total Assets 64.08
Total Liabilities 64.08
Total Equity 57.23
Share Outstanding 19931200
Price to Book Ratio 4.18
Return on Assets (%) 2.79
Return on Capital (%) 3.12
Particulars MAR 2023 (Values in Cr)
Net Income 2.71
Cash from Operations 11.21
Cash from Investing -10.09
Cash from Financing 0.00
Net change in Cash 0.44
Free Cash Flow 11.21
Particulars MAR 2022 (Values in Cr)
Net Income 3.49
Cash from Operations 4.54
Cash from Investing -3.36
Cash from Financing -0.19
Net change in Cash 0.01
Free Cash Flow 4.54
Particulars MAR 2021 (Values in Cr)
Net Income 0.42
Cash from Operations 2.47
Cash from Investing -2.35
Cash from Financing 0.00
Net change in Cash 0.00
Free Cash Flow 2.47
Particulars MAR 2020 (Values in Cr)
Net Income 0.23
Cash from Operations -1.00
Cash from Investing 0.98
Cash from Financing 0.00
Net change in Cash -0.02
Free Cash Flow -1.00
Particulars MAR 2019 (Values in Cr)
Net Income 1.78
Cash from Operations -0.49
Cash from Investing -32.06
Cash from Financing 32.58
Net change in Cash 0.01
Free Cash Flow -0.49
Company Name Price P/E P/B Market Cap 52 Week Low/High
BLISS GVS PHARMA LTD 114.00 12.46 1.23 1194.01 77.65 / 148.95
CIPLA LTD 1511.35 28.66 4.56 122044.23 1020.00 / 1581.70
FERMENTA BIOTECH LIMITED 213.15 0.00 2.16 627.32 136.60 / 219.05
GLAXOSMITHKLINE PHARMA LT 2611.55 67.38 24.88 44241.23 1376.50 / 2759.00
SANOFI INDIA LIMITED 6388.45 25.93 14.49 14712.60 5850.55 / 10526.05
Company Name Price P/E P/B Market Cap 52 Week Low/High
Shree Ganesh Biotech (India) L 1.25 62.50 0.79 49.83 0.70 / 1.89
AMRUTAJAN HEALTH LTD 742.65 47.73 7.44 2147.05 556.05 / 826.00
ASTRAZENECA PHARMA IND LT 6566.50 109.81 23.05 16416.25 3715.05 / 7550.00
BLISS GVS PHARMA LTD 114.00 15.68 1.20 1194.01 77.65 / 148.95
ABBOTT INDIA LIMITED 28602.85 50.60 16.43 60781.06 21907.45 / 29628.15

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 1.30
  • 26 Days 1.20
  • 10 Days 1.30
  • 50 Days 1.20
  • 12 Days 1.20
  • 100 Days 1.20
  • 20 Days 1.20
  • 200 Days 0.90
1.22
PIVOT
First Resistance 1.29
Second Resistance 1.32
Third Resistance 1.39
First Support 1.19
Second Support 1.12
Third Support 1.09
RSI 59.61
MACD 0.03
Commodity Channel Index (CCI) 14.74
ADX 28.87
Williams % R -61.29

Over 1 Month

down

9.64

Over 3 Months

down

2.45

Over 6 Months

down

-14.38

Over 1 Year

down

19.04

Over 3 Years

down

-40.41

Over 5 Years

down

-26.92

Shree Ganesh Biotech (India) L Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

Shree Ganesh Biotech (India) L Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Others
97.82
Promoter Holdings
0.0
FII
2.17
DII
0.0
Promoter Shares(Pledge Percentage)
0.0
Name Category Shares Shares%
New Era Fund Limited Public Shareholding 5664940.0 1.42

Shree Ganesh Biotech (India) L

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
Ex-Date Ex-Bonus Ratio
2022-04-28 2022-04-27 1:1
Ex-Date Old FV NEW FV Record Date
2022-02-10 10.0 1.0 2022-02-11

Learn More About Stocks

About Shree Ganesh Biotech (India) L

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by Shree Ganesh Biotech (India) L

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 5x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Shree Ganesh Biotech India Ltd?

Answer Field

The share price of Shree Ganesh Biotech India Ltd for NSE is ₹ 0.00 and for BSE is ₹ 1.21.

What is the Market Cap of Shree Ganesh Biotech India Ltd?

Answer Field

The market cap of Shree Ganesh Biotech India Ltd for NSE is ₹ 0.0 Cr. and for BSE is ₹ 48.20 Cr. as of now.

What is the 52 Week High and Low of Shree Ganesh Biotech India Ltd?

Answer Field

The 52 Week High and Low of Shree Ganesh Biotech India Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 1.89 and ₹ 0.70.

How to Buy Shree Ganesh Biotech India Ltd share?

Answer Field

You can trade in Shree Ganesh Biotech India Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Shree Ganesh Biotech India Ltd?

Answer Field

The 1 year returns on the stock has been 19.04%.

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

7.5 Lacs+ Users

icon-with-text

4.3+ App Rating

icon-with-text

4 Languages

icon-with-text

₹4300 Cr MTF Book

icon-with-text
loader